StockData
Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc. (CABA) stock

CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$1.01−0.04 (-4.27%)

Close on Nov 19, 2026Market cap $171.24MP/E –Yield –

Cabaletta Bio shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Cabaletta Bio's shares outstanding was 151M at Jun 30, 2026. For fiscal 2023 it was 1M, down 80.3% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2023Dec 31, 20231M-80.3%
FY2022Dec 31, 20226M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026151M+12841.2%
Q1 FY2026Mar 31, 2026112M+9490.8%
Q2 FY2025Jun 30, 202562M+1398.1%
Q1 FY2025Mar 31, 202551M+1128.5%
Q2 FY2024Jun 30, 20241M-45.5%
Q1 FY2024Mar 31, 20241M-35.1%
Q2 FY2023Jun 30, 20234M+321.9%
Q1 FY2023Mar 31, 20234M–
Q3 FY2019Sep 30, 20192M–
Q2 FY2019Jun 30, 20192M–
Q3 FY2018Sep 30, 20181M–

More Cabaletta Bio figures

See a number that looks wrong?